Michelle Petri, MD MPH

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Ermium
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    08/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Exo Therapeutics
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    08/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Genentech
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Gentibio
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    01/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    GSK
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    iCell Gene Therapeutics
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    11/30/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Innovaderm
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    02/28/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    iTabMed
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Kymera Therapeutics
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Merck EMD Serono
    Topic:
    Chickungunya
    Date added:
    04/28/2026
    Date updated:
    04/28/2026

Pages

Return to 2026 Florida Society of Rheumatology Annual Meeting